UnitedHealth Group Incorporated $UNH Shares Sold by Tranquility Partners LLC

Tranquility Partners LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,615 shares of the healthcare conglomerate’s stock after selling 349 shares during the quarter. UnitedHealth Group comprises approximately 1.0% of Tranquility Partners LLC’s investment portfolio, making the stock its 21st largest holding. Tranquility Partners LLC’s holdings in UnitedHealth Group were worth $2,688,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. Asset Planning Inc increased its holdings in shares of UnitedHealth Group by 3.3% during the second quarter. Asset Planning Inc now owns 1,900 shares of the healthcare conglomerate’s stock valued at $593,000 after acquiring an additional 61 shares in the last quarter. Sivik Global Healthcare LLC increased its holdings in UnitedHealth Group by 200.0% in the 2nd quarter. Sivik Global Healthcare LLC now owns 15,000 shares of the healthcare conglomerate’s stock worth $4,680,000 after buying an additional 10,000 shares during the period. GFS Advisors LLC acquired a new position in UnitedHealth Group in the 2nd quarter worth approximately $4,524,000. Keener Financial Planning LLC increased its holdings in UnitedHealth Group by 411.0% in the 2nd quarter. Keener Financial Planning LLC now owns 373 shares of the healthcare conglomerate’s stock worth $116,000 after buying an additional 300 shares during the period. Finally, Fifth Third Wealth Advisors LLC increased its holdings in UnitedHealth Group by 5.4% in the 2nd quarter. Fifth Third Wealth Advisors LLC now owns 15,566 shares of the healthcare conglomerate’s stock worth $4,856,000 after buying an additional 794 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 3.6%

Shares of NYSE:UNH opened at $354.30 on Friday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm has a market capitalization of $320.88 billion, a price-to-earnings ratio of 15.35, a price-to-earnings-growth ratio of 2.29 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The business’s 50 day moving average price is $318.21 and its 200-day moving average price is $349.25.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Analysts Set New Price Targets

UNH has been the topic of several research reports. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Mizuho raised their price objective on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday. Truist Financial raised their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research note on Tuesday, September 9th. Bank of America raised their price objective on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Wednesday. Finally, Sanford C. Bernstein raised their price objective on shares of UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a research note on Wednesday. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $383.09.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.